{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:29:10Z","timestamp":1790386150499,"version":"4.1.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23AR070286"],"award-info":[{"award-number":["K23AR070286"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rates of incident treatment were quantified in this study for diabetes mellitus, hypertension, and venous thromboembolism (VTE) associated with oral glucocorticoid exposure in children aged 1\u201318 years. The retrospective cohort included more than 930,000 children diagnosed with autoimmune diseases (namely, inflammatory bowel disease, juvenile idiopathic arthritis, or psoriasis) or a nonimmune comparator condition (attention-deficit\/hyperactivity disorder) identified using US Medicaid claims (2000\u20132010). Associations of glucocorticoid dose per age- and sex-imputed weight with incident treated diabetes, hypertension, and VTE were estimated using Cox regression models. Crude rates were lowest for VTE (unexposed: 0.5\/million person-days (95% confidence interval (CI): 0.4, 0.6); currently exposed: 15.6\/million person-days (95% CI: 11.8, 20.1)) and highest for hypertension (unexposed: 6.7\/million person-days (95% CI: 6.5, 7.0); currently exposed: 74.4\/million person-days (95% CI: 65.7, 83.9)). Absolute rates for all outcomes were higher in unexposed and exposed children with autoimmune diseases compared with those with attention-deficit\/hyperactivity disorder. Strong dose-dependent relationships were found between current glucocorticoid exposure and all outcomes (adjusted hazard ratios for high-dose glucocorticoids: for diabetes mellitus, 5.93 (95% CI: 3.94, 8.91); for hypertension, 19.13 (95% CI: 15.43, 23.73); for VTE, 16.16 (95% CI: 8.94, 29.22)). These results suggest strong relative risks, but low absolute risks, of newly treated VTE, diabetes, and especially hypertension in children taking high-dose oral glucocorticoids.<\/jats:p>","DOI":"10.1093\/aje\/kwaa197","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T15:13:52Z","timestamp":1599232432000},"page":"403-412","source":"Crossref","is-referenced-by-count":17,"title":["Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in Children"],"prefix":"10.1093","volume":"190","author":[{"given":"Daniel B","family":"Horton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L","family":"Mannion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L","family":"Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Beukelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"issue":"19","key":"2021043012070315200_ref1","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.2018.5690","article-title":"Trends in prescription medication use among children and adolescents-United States, 1999-2014","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"2021043012070315200_ref2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4146","article-title":"Oral corticosteroid prescribing for children with asthma in a Medicaid managed care program","volume":"139","author":"Farber","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"2021043012070315200_ref3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2310\/7750.2013.13126","article-title":"Systemic corticosteroids are frequently prescribed for psoriasis","volume":"18","author":"Al-Dabagh","year":"2014","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"2021043012070315200_ref4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/09546634.2017.1365112","article-title":"Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace","volume":"29","author":"Alexander","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"2021043012070315200_ref5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"2021043012070315200_ref6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016788","article-title":"Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort study","volume":"7","author":"Horton","year":"2017","journal-title":"BMJ Open"},{"issue":"15","key":"2021043012070315200_ref7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"2021043012070315200_ref8","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1542\/peds.2012-1292","article-title":"Prehypertension and hypertension in community-based pediatric practice","volume":"131","author":"Lo","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"2021043012070315200_ref9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jamapediatrics.2014.3216","article-title":"Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012","volume":"169","author":"Kit","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2021043012070315200_ref10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2195","article-title":"Diagnosis and medication treatment of pediatric hypertension: a retrospective cohort study","volume":"138","author":"Kaelber","year":"2016","journal-title":"Pediatrics"},{"key":"2021043012070315200_ref11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpeds.2016.02.017","article-title":"Incidence trends and mortality from childhood venous thromboembolism: a population-based cohort study","volume":"172","author":"Sabapathy","year":"2016","journal-title":"J Pediatr"},{"issue":"1","key":"2021043012070315200_ref12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.1994.00420010131015","article-title":"Glucocorticoids and the risk for initiation of hypoglycemic therapy","volume":"154","author":"Gurwitz","year":"1994","journal-title":"Arch Intern Med"},{"issue":"9","key":"2021043012070315200_ref13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1525-1497.2002.10649.x","article-title":"Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly","volume":"17","author":"Blackburn","year":"2002","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2021043012070315200_ref14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/art.39537","article-title":"Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis","volume":"68","author":"Movahedi","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"2021043012070315200_ref15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/pds.3890","article-title":"Risks of hypertension associated with cyclosporine, nonsteroidal anti-inflammatory drugs, and systemic glucocorticoids in patients with psoriasis: a nationwide population-based nested case-control study in Taiwan","volume":"25","author":"Lee","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"2021043012070315200_ref16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom","volume":"167","author":"Huerta","year":"2007","journal-title":"Arch Intern Med"},{"issue":"9","key":"2021043012070315200_ref17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"3","key":"2021043012070315200_ref18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2021043012070315200_ref19","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"Fardet","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2021043012070315200_ref20","author":"Global Initiative for Asthma","year":"2018"},{"key":"2021043012070315200_ref21","volume-title":"Pharmacoepidemiology","author":"Horton","year":"2019","edition":"6th"},{"issue":"26","key":"2021043012070315200_ref22","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"2021043012070315200_ref23","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients","volume":"108","author":"Caruso","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2021043012070315200_ref24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1399-3046.2007.00862.x","article-title":"Post-transplant diabetes mellitus in children following renal transplantation","volume":"12","author":"Prokai","year":"2008","journal-title":"Pediatr Transplant"},{"issue":"5","key":"2021043012070315200_ref25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.healun.2008.01.018","article-title":"Hypertension after pediatric heart transplantation is primarily associated with immunosuppressive regimen","volume":"27","author":"Roche","year":"2008","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"2021043012070315200_ref26","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbmt.2009.05.010","article-title":"Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2021043012070315200_ref27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/193229681200600102","article-title":"Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit","volume":"6","author":"Wintergerst","year":"2012","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"2021043012070315200_ref28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2000.109830","article-title":"Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma","volume":"106","author":"Covar","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"2021043012070315200_ref29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"2021043012070315200_ref30","volume-title":"Pediatric Endocrinology","author":"Walter","year":"2008"},{"key":"2021043012070315200_ref31","author":"Centers for Disease Control and Prevention, National Center for Health Statistics","year":"2017"},{"issue":"4","key":"2021043012070315200_ref32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"2021043012070315200_ref33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(81)80955-9","article-title":"Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone","volume":"99","author":"Pui","year":"1981","journal-title":"J Pediatr"},{"issue":"6","key":"2021043012070315200_ref34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00007890-200109270-00007","article-title":"Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"72","author":"Al-Uzri","year":"2001","journal-title":"Transplantation"},{"issue":"2","key":"2021043012070315200_ref35","first-page":"103","article-title":"Steroid-induced diabetes in pediatric renal transplant recipients","volume":"4","author":"Fennell","year":"1983","journal-title":"Int J Pediatr Nephrol"},{"issue":"1","key":"2021043012070315200_ref36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1399-3046.2012.01779.x","article-title":"Characteristics of diabetes after pediatric liver transplant","volume":"17","author":"Greig","year":"2013","journal-title":"Pediatr Transplant"},{"issue":"3","key":"2021043012070315200_ref37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1399-3046.2005.00455.x","article-title":"Characteristics of long-term live-donor pediatric renal transplant survivors: a single-center experience","volume":"10","author":"El-Husseini","year":"2006","journal-title":"Pediatr Transplant"},{"issue":"6","key":"2021043012070315200_ref38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00467-013-2721-3","article-title":"Post-transplant hypertension in pediatric kidney transplant recipients","volume":"29","author":"G\u00fclhan","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"2021043012070315200_ref39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0049-3848(01)00286-9","article-title":"Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase\/prednisone administration","volume":"103","author":"Nowak-G\u00f6ttl","year":"2001","journal-title":"Thromb Res"},{"issue":"6","key":"2021043012070315200_ref40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/1076029612475022","article-title":"The risk factors for thrombosis in children with acute lymphoblastic leukemia","volume":"20","author":"Sivaslioglu","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"2021043012070315200_ref41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MPH.0b013e31828dc614","article-title":"Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience","volume":"35","author":"Santoro","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"2021043012070315200_ref42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","article-title":"Epidemiology and comorbidity of psoriasis in children","volume":"162","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1","key":"2021043012070315200_ref43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/acr.23094","article-title":"Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study","volume":"69","author":"Jafri","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"39","key":"2021043012070315200_ref44","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1093\/eurheartj\/ehx145","article-title":"Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study","volume":"39","author":"Ogdie","year":"2018","journal-title":"Eur Heart J"},{"issue":"8","key":"2021043012070315200_ref45","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1160\/TH17-01-0039","article-title":"Increased risks of venous thromboembolism in patients with psoriasis. A nationwide cohort study","volume":"117","author":"Chung","year":"2017","journal-title":"Thromb Haemost"},{"issue":"3","key":"2021043012070315200_ref46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/MPG.0b013e31829ce5cd","article-title":"Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease","volume":"57","author":"Zitomersky","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"2021043012070315200_ref47","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"issue":"5","key":"2021043012070315200_ref48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/rheumatology\/34.5.466","article-title":"Increase of activated factor VIIA and haemostatic molecular markers in juvenile chronic arthritis","volume":"34","author":"Inamo","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"2","key":"2021043012070315200_ref49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.ajp.2011.10111705","article-title":"Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD","volume":"169","author":"Vitiello","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"6","key":"2021043012070315200_ref50","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1093\/pch\/pxx207","article-title":"Blood pressure in children with attention deficit\/hyperactivity disorder","volume":"23","author":"Grisaru","year":"2018","journal-title":"Paediatr Child Health"},{"issue":"9677","key":"2021043012070315200_ref51","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"2021043012070315200_ref52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.112.128751","article-title":"Elevated blood pressure in pregnancy and subsequent chronic disease risk","volume":"127","author":"M\u00e4nnist\u00f6","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"2021043012070315200_ref53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/archdischild-2015-309522","article-title":"Systematic review of the toxicity of short-course oral corticosteroids in children","volume":"101","author":"Aljebab","year":"2016","journal-title":"Arch Dis Child"},{"issue":"9","key":"2021043012070315200_ref54","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/aje\/154.9.854","article-title":"Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data","volume":"154","author":"Schneeweiss","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2021043012070315200_ref55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2288-12-128","article-title":"Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid study","volume":"12","author":"Bobo","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"2021043012070315200_ref56","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2015.0285","article-title":"Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths","volume":"169","author":"Rubin","year":"2015","journal-title":"JAMA Pediatr"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwaa197\/35198052\/kwaa197.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/190\/3\/403\/37671410\/kwaa197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/190\/3\/403\/37671410\/kwaa197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T18:00:38Z","timestamp":1696615238000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/190\/3\/403\/5902909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9,9]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwaa197","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2020,9,9]]}}}